Contact: Teresa Herbert
Dana-Farber Cancer Institute
Caption: Dr. Irene Ghobrial led a study showing a drug that targets the driver mutation in patients with Waldenstrom's Macrogloblinemia is proving effective in animal studies.
Credit: Dana-Farber Cancer Institute
Usage Restrictions: None
Related news release: Gene 'driver' of Waldenstrom's Macroglobulinemia in up to one-third of patients identified